基准韩国综合股价指数周三下跌1.3%,收于2596点,结束了连续六天的上涨,受健康和金融股大幅下跌的拖累。在健康公司中,三星生物制品下跌1%,而Celltrion和Alteogen分别下跌2.7%和6.4%。此外,金融业面临压力,KB Financial(-4.2%)、新韩金融(-4.8%)和Hana Financial(-2.5%)均出现下跌。在企业新闻方面,三星电子已与现代和起亚合作,将其SmartThings物联网平台集成到他们的汽车中,并与诺基亚、爱立信和沃达丰Idea签署了一项价值36亿美元的4G和5G网络设备协议。尽管如此,这家芯片巨头下跌了1%,而其同行SK海力士上涨了1.4%。在经济数据方面,韩国9月消费者信心指数降至100.0,比8月下降0.8点,而公共部门净贷款赤字从2022年的58.7万亿韩元降至2023年的46.4万亿韩元。
The benchmark KOSPI shed 1.3% to close at 2,596 points on Wednesday, ending a six-day winning streak, weighed down by sharp losses in health and financial stocks. Among health firms, Samsung Biologics tumbled 1%, while Celltrion and Alteogen dropped 2.7% and 6.4%, respectively. Additionally, financials faced pressure, with decreases seen from KB Financial (-4.2%), Shinhan Financial (-4.8%), and Hana Financial (-2.5%). In corporate news, Samsung Electronics has teamed up with Hyundai and Kia to integrate its SmartThings IoT platform into their vehicles and has signed a $3.6 billion deal with Nokia, Ericsson, and Vodafone Idea for 4G and 5G network equipment. Despite this, the chip giant dipped 1%, while its peer SK Hynix climbed 1.4%. On the economic data front, South Korea's consumer sentiment index fell to 100.0 in September, down 0.8 points from August, while the public sector net lending deficit shrank to 46.4 trillion won in 2023 from 58.7 trillion won in 2022.